<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347900">
  <stage>Registered</stage>
  <submitdate>4/01/2012</submitdate>
  <approvaldate>17/01/2012</approvaldate>
  <actrnumber>ACTRN12612000084886</actrnumber>
  <trial_identification>
    <studytitle>Hyperbaric Oxygen Therapy for Radiation Induced Xerostomia (Dry Mouth)</studytitle>
    <scientifictitle>Hyperbaric oxygen therapy versus control to assess affect on quality of life and saliva analysis in patients with established xerostomia following radiotherapy in head and neck cancer.</scientifictitle>
    <utrn>U1111-1126-8018</utrn>
    <trialacronym>HOTRIX</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Soft tissue radiation injury to salivary glands (xerostomia)</healthcondition>
    <healthcondition>Head and Neck Cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Head and neck</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Hyperbaric oxygen therapy at 2.4 ATA for 30 treatments.
Each treatment is 90 mins, daily (Mon-Fri) for 6 weeks.This would be at least 6 months after completion of radiotherapy.The treatment is given in a monoplace hyperbaric chamber so no hoods/ masks are required.</interventions>
    <comparator>normobaric air at 1.1 ATA for 30 treatments</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of life score with XQ scoring system</outcome>
      <timepoint>baseline
end of  hyperbaric oxygen treatment 
3 months
6 months
12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>saliva anlaysis ( pH, flow and consistency). This is tested with a dental kit which allows scoring of saliva flow. The subject need only give a spit sample which is timed over a couple of minutes.</outcome>
      <timepoint>prior to  hyperbaric oxygen treatment
 immediately after  hyperbaric oxygen treatment
3 months post hyperbaric oxygen treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>bacterial genomic study of saliva</outcome>
      <timepoint>baseline
end of treatment
3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Dental extraction rate as reported by subject in a diary which is issued to them at commencement of enrolment.</outcome>
      <timepoint>3 months
6 months
12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Participants self report costs as estimated by them in a diary e.g transport to hospital for appointments,saliva analogues, dental visits, speech pathology appointments.</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>head and neck cancer with radiation therapy&gt;50Gy
established xerostomia of at least  6 months duration
no contraindiations to hyperbaric oxygen therapy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindication to hyperbaric therapy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation concealment is achieved with sealed envelopes.</concealment>
    <sequence>Sequencing of patients into control and intervention groups will be generated using a computer algorithm to generate a random sequence. This will be done with the help of the biostatistician at QIMR.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Patients in control group will be offerred the treatment after the 3 month assessmnet as requested by our HREC due to the long time frame of the treatment.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>19/06/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr S Sherlock</primarysponsorname>
    <primarysponsoraddress>Hyperbaric Medicine Service
RBWH
Butterfield St
Herston
Qld 4029</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>RBWH Research Trust</fundingname>
      <fundingaddress>RBWH
Butterfield St
Herston
Qld 4029</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Robert Webb</sponsorname>
      <sponsoraddress>Director of Hyperbaric Medicne Service
RBWH
Butterfield St
Herston
Qld 4029</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Graham Dickie</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and womens hospital
Butterfeild st
Herston
State: QLD
Postcode: 4029
Country: Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Alan Bourke</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and womens hospital
Butterfield st
Herston
State: QLD
Postcode: 4029
Country: Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>DR Caroline Acton</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and womens hospital
Butterfield st
Herston
State: QLD
Postcode: 4029
Country: Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Lee Jones</othercollaboratorname>
      <othercollaboratoraddress>QIMR
300 Herston Rd
Herston
Qld 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Assoc Prof David Reid</othercollaboratorname>
      <othercollaboratoraddress>QIMR
300 Herston Rd
Herston
Qld 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Mr David King</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and womens hospital
Butterfield St
Herston
State: QLD
Postcode: 4029
Country: Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will assess the effect of hyperbaric oxygen therapy on quality of life and saliva in patients with dry mouth (xerostomia) following radiotherapy for head and neck cancer. 

Who is it for? 
You may be eligible to join this study if you are aged 18-90 years and have been diagnosed with xerostomia of at least 6 months duration following radiotherapy for head and neck cancer. 

Trial details
Participants in this trial will be randomly (by chance ) allocated to one of two groups. Participants in one group will undergo 30 daily hyperbaric oxygen treatments of 90 minutes duration each. Participants in the other group will receive 30 placebo (control) treatments initially but will be offered the hyperbaric oxygen treatment after 3 months. Participants will not know which group they are in until the trial is completed.

Participants will be regularly assessed over a 12 month period to determine their quality of life, saliva components and treatment costs.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>RBWH HREC</ethicname>
      <ethicaddress>RBWH
Butterfield St
Herston
Brisbane
QLD 4029</ethicaddress>
      <ethicapprovaldate>2/11/2011</ethicapprovaldate>
      <hrec>HREC/11/QRBW/398</hrec>
      <ethicsubmitdate>17/10/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Susannah Sherlock</name>
      <address>Hyperbaric Medicine Service
RBWH
Butterfield St
Herston 
Qld 4029</address>
      <phone>+61736360241</phone>
      <fax>+61736360747</fax>
      <email>susannah_sherlock@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Susannah Sherlock</name>
      <address>Hyperbaric Medicine Service
RBWH
Butterfield St
Herston 
Qld 4029</address>
      <phone>+61736360241</phone>
      <fax>+61736360747</fax>
      <email>susannah_sherlock@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Research Nurse TBA</name>
      <address>Hyperbaric Medicine Service
RBWH
Butterfield St
Herston 
Qld 4029</address>
      <phone>+61736360241</phone>
      <fax>+61736360747</fax>
      <email>kerri_howie@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>